4-Pro-Met Drops

4-Pro-Met drops combine the analytical purity of 4-Pro-Met with the precise dosability of the drops format. HPLC ≥99 %, ±5 % unit-dose tolerance, documented batches. Research chemical for lab use only. This page explains why this substance-format pairing is chosen for reproducible research protocols.

Why 4-Pro-Met as drops? — The Combination in Detail

The combination of 4-Pro-Met with the dosage form drops is selected because the pharmacokinetic profile of the substance harmonises well with the properties of this format. Reproducible dose-response relationships require that both substance and carrier matrix remain constant. Varying even one of these variables introduces scatter that cannot be cleanly attributed in subsequent analysis.

Why this format for 4-Pro-Met?

• drops provide a unit-dose tolerance of ±5 %, essential for reproducible research data
• Chemical compatibility of 4-Pro-Met with the carrier matrix is documented and does not adversely affect stability throughout shelf life
• The format works with standard storage protocols (cool, light-protected, dry) without additional protective measures
• Unit-wise dispensing removes the need to weigh tiny substance amounts, reducing systematic dosing error
• Batch-to-batch reproducibility is minimised through identical manufacturing protocols

Comparison of dosage forms for 4-Pro-Met

drops are an established format for reproducible research data with fixed standard dose. Drops offer flexibility through stepless volumetric adjustment and are better suited for dose-escalation studies. Pellets sit between: fixed unit like blotters, but with higher storage stability through the cellulose matrix. Format selection follows the specific study design.

Standard dose in the literature

For 4-Pro-Met, typical dose tiers are described in the pharmacological research literature, aligned with the pharmacodynamic profile. The units in our 4-Pro-Met drops match these established tiers so that research data remains directly comparable with published studies. Exact dose levels are listed in the respective product description.

Demarcation from clinical use

4-Pro-Met drops are not medicinal products and are not approved for human administration. Phase I clinical safety data for most lysergamide research chemicals do not exist. The products offered here serve exclusively analytical and pharmacological research in a laboratory context.

Integration into a research protocol

Before 4-Pro-Met drops enter a study, the standard sequence is: (1) identity confirmation against the supplied COA (retention time ±0.1 min, mass spectrum match), (2) content verification by HPLC against an internal calibration curve, (3) stability assessment for the planned study duration, (4) documentation in the laboratory journal with batch ID and storage location. This four-step procedure is the minimum for GLP-compliant research and is also recommended for non-GLP exploratory work because it eliminates the substance identity itself as a confounding variable.

Comparison to bulk-substance procurement

Compared with ordering raw 4-Pro-Met substance and dosing in-house, pre-dispensed drops reduce total study cost considerably: no analytical balance with µg sensitivity required, no dedicated weighing room, no fume-hood time for dispensing, no internal QC of every dispensed aliquot. For small to mid-size studies (n < 200) the unit economics almost always favour pre-dispensed format.

Quality & Purity — How HPLC Testing Works

HPLC procedure — what is measured

Every batch of 4-Pro-Met undergoes high-performance liquid chromatography (HPLC) analysis for purity and identity before release. HPLC separates the substance from potential impurities (synthesis by-products, solvent residues, degradation products) and yields a quantifiable chromatogram. The main peak represents the target substance; secondary peaks below our 1.0 % specification limit are considered acceptable.

What appears in the COA (Certificate of Analysis)?

• Chromatogram: retention time and integration area of the main peak
• Purity statement: ≥99 % (area-percent evaluation)
• Identity spectrum: comparison with reference data of the lysergamide compound
• Batch ID: traceable identifier with production and analysis date
• Stability data: specification of storage conditions for declared shelf life

COA / purity documentation exists per batch and is available on request via support. We do not include the document in every package by default but provide it to every researcher who supplies the relevant batch ID. Purity remains verifiable without burdening every order with additional paperwork.

What ≥99 % purity actually means

The 99 % specification is an area-percent value from the HPLC chromatogram, not a weight percent. It states that 99 % or more of the detected absorbance signal at the analytical wavelength is attributable to the main peak (the target substance) and ≤1 % to the sum of all other detectable peaks (related substances, isomers, synthesis-route by-products). For lysergamides this specification matches the regulatory benchmark used for forensic reference materials.

Quality boundaries — what HPLC cannot show

HPLC at a single wavelength is sensitive to UV-active impurities but blind to certain residual solvents and inorganic contaminants. For complete characterisation our QC adds Karl Fischer titration (residual water), GC headspace analysis (residual solvents to ICH Q3C limits) and ash determination. The full picture of substance identity, purity and process residues is documented in the COA.

Difference between research-grade and pharma-grade material

Research-grade material follows the analytical purity specification (≥99 % HPLC) but is not subject to GMP manufacturing. For analytical, forensic and non-human pharmacological research this specification is sufficient. For clinical or human-subject research a GMP material at additional cost and lead time would be required — outside the scope of this catalogue.

Research Applications in Pharmacology

Lysergamides like 4-Pro-Met are used in several established research fields. The substance serves exclusively as an analytical or pharmacological tool in the laboratory.

Typical research applications

• Receptor binding studies: affinity and selectivity measurements at the 5-HT2A receptor, including comparison with reference ligands such as ketanserin or LSD itself
• Functional assays: investigation of G-protein–mediated signalling pathways (Gq/11), β-arrestin recruitment, IP accumulation in cell systems
• Pharmacokinetic profiles: determination of half-life, volume of distribution and metabolite formation in animal models or human microsomes
• Analytical method development: setup and validation of detection methods (LC-MS/MS, GC-MS, ELISA) for forensic and toxicological applications
• Comparative studies: structure-activity relationship (SAR) studies among different lysergamides
• Stability studies: investigation of chemical stability under different storage conditions (temperature, light, humidity)

Use is exclusively in a laboratory context by trained research personnel. Human administration is not permitted and not intended.

Methodological considerations for 4-Pro-Met studies

When designing a study with lysergamide research chemicals, several methodological choices significantly affect reproducibility: (1) solvent system — DMSO at low concentration (≤0.1 % v/v) is the standard, since aqueous solubility is limited; (2) incubation conditions — lysergamides degrade under prolonged light and elevated temperature, so working solutions should be freshly prepared; (3) reference compound — co-running LSD or a documented analogue alongside the test compound provides internal validation; (4) positive/negative controls — ketanserin (5-HT2A antagonist) and a structurally unrelated ligand help anchor the response window.

Reporting standards

For publishable results, the typical reporting items are: batch ID and supplier, purity (HPLC area-percent), solvent system, working concentration range (with calculated final molarity), cell line or animal model with passage / generation, n per condition, statistical method. Including the COA reference and batch ID in supplementary data is increasingly required by reviewers when research chemicals are used.

Storage, Stability & Half-Life

Recommended storage conditions

• Temperature: cool, 2–8 °C (refrigerator). Storage above 25 °C significantly shortens shelf life
• Light protection: lysergamides are UV-sensitive. Use original packaging or store in an opaque container
• Humidity: store dry (relative humidity < 60 %). Use desiccant if needed
• Packaging: keep original packaging sealed. Repeated opening reduces purity through contamination

Shelf life and stability

Under correct storage, shelf life for 4-Pro-Met is at least 12 months. Stability data from our batches show a purity loss of typically <1 % per year under spec-compliant storage. Higher storage temperatures (continuous room temperature) accelerate degradation — the nominal shelf life shortens to about 6 months.

The chemical half-life under storage conditions must not be confused with the pharmacokinetic half-life in a biological system. The former describes chemical stability, the latter the elimination kinetics in vivo.

Legal Status 2026 — What to Check Before Ordering

EU legal classification (as of 2026)

The legal status of lysergamide research chemicals varies substantially between EU member states. In Germany the New Psychoactive Substances Act (NpSG) has applied since 2016, regulating certain substance groups in bulk. Lysergamides with modified substituents fall either under the substance-group definition or remain outside, depending on exact structure.

• BtMG status: most 4-Pro-Met variants are not listed in the Narcotics Act; confirm current status in annexes I–III
• NpSG status: the lysergamide group is covered in bulk; research and analytics exemptions apply with conditions
• Other EU countries: the Netherlands, Poland, Czech Republic and Spain regulate lysergamide research chemicals differently
• Buyer responsibility: verifying current legal status at the buyer's location rests entirely with the buyer

We supply exclusively for research and analytical purposes. We do not ship to countries with clearly restrictive legislation. When uncertain, we recommend consulting legal advice or the responsible authority before ordering.

Shipping, Packaging & Payment

EU shipping & packaging

• Delivery time: typically 48 hours within the EU; same-business-day shipment for orders placed by 14:00
• Packaging: neutral outer packaging without inference about contents
• Shipping costs: free above €50 order value; flat rate below
• Tracking: tracking number by email with shipping confirmation

Payment & data protection

• Payment method: SEPA bank transfer (secure, established within the EU)
• Data processing: exclusively for contract processing; no transfer to third parties outside the logistics chain
• Retention obligation: statutory retention periods for invoice documents are observed (HGB/AO)

Ordering 4-Pro-Met — How It Works

Ordering process

1. Select product: place desired substance, form and quantity in the cart
2. Checkout: provide delivery address and SEPA bank details in the secure checkout
3. Payment: transfer via SEPA using the details given in the confirmation email
4. Shipping: with payment received by 14:00, same-business-day shipment; otherwise next business day
5. Delivery: typically 48 hours EU-wide from dispatch

For questions on batch, COA or legal status, contact our support by email. Typical response time is within one business day.